172 related articles for article (PubMed ID: 6139506)
1. [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
Lil'in ET; Vavilova TA; Mar'in MI
Klin Med (Mosk); 1983 Sep; 61(9):85-9. PubMed ID: 6139506
[No Abstract] [Full Text] [Related]
2. [Antihypertensive effect of beta-blockaders].
Liebau H; Jarosch von Schweder W
Verh Dtsch Ges Inn Med; 1974; 80():268-72. PubMed ID: 4156114
[No Abstract] [Full Text] [Related]
3. [Beta-blockers and arterial hypertension in the aged patient].
Emeriau JP; Rumeau M
Nouv Presse Med; 1978 Sep; 7(31):2803-6. PubMed ID: 30969
[No Abstract] [Full Text] [Related]
4. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
Bjerle P; Jacobsson KA; Agert G
Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
[No Abstract] [Full Text] [Related]
5. [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
Pieniazek W; Franczuk P; Janicki K
Przegl Lek; 2001; 58(5):411-4. PubMed ID: 11603173
[TBL] [Abstract][Full Text] [Related]
6. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
Kirch W; von Gizycki C
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
[No Abstract] [Full Text] [Related]
7. Comparative study with Tobanum and Visken in hypertensive patients.
Torma Z; Grubic V; Unyi G
Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
[No Abstract] [Full Text] [Related]
8. [Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Halawa B
Pol Tyg Lek; 1987 Feb; 42(6):153-5. PubMed ID: 3037504
[No Abstract] [Full Text] [Related]
9. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
Reffo GC; Pitzorno G; Perin S; Forattini C
Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
[TBL] [Abstract][Full Text] [Related]
10. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.
Collins IS; King IW
Curr Ther Res Clin Exp; 1972 Apr; 14(4):185-94. PubMed ID: 4402011
[No Abstract] [Full Text] [Related]
11. [Evaluation of the hypotensive effect of acebutolol (Sectral)].
Brym E; Cybulska I; Czerniewska E
Pol Tyg Lek; 1982 Nov; 37(44):1323-6. PubMed ID: 6761673
[No Abstract] [Full Text] [Related]
12. [beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Dubois D; Petitcolas J
Nouv Presse Med; 1978 Sep; 7(31):2811-2. PubMed ID: 30971
[No Abstract] [Full Text] [Related]
13. [Antihypertensive therapy with left cardiac insufficiency].
Schröder H
Med Monatsschr Pharm; 2005 Dec; 28(12):443-4. PubMed ID: 16389872
[No Abstract] [Full Text] [Related]
14. [Therapy of hypertension using various beta receptor blockaders (timolol, alprenolol, prindolol].
Heinze A; Wessels F; Losse H
Verh Dtsch Ges Kreislaufforsch; 1975; 41():380-2. PubMed ID: 7887
[No Abstract] [Full Text] [Related]
15. [Effects of new beta receptor blocking agent Acebutolol in patients with essential, renal, and broderline hypertension].
Werning C
Med Welt; 1977 Sep; 28(39):1564-6. PubMed ID: 22016
[No Abstract] [Full Text] [Related]
16. The treatment of arterial hypertension with acebutolol. Its effect on the urinary catecholamine excretion.
Streian C; Comşulea L; Deutsch G; Mangiuca M; Ienea A
Med Interne; 1981; 19(3):259-63. PubMed ID: 7302505
[No Abstract] [Full Text] [Related]
17. Beta-blockade for hypertension.
Drug Ther Bull; 1974 Apr; 12(9):33-5. PubMed ID: 4156667
[No Abstract] [Full Text] [Related]
18. [Antihypertensive effect and inhibition of the sympathetic nervous system by acebutolol].
Hardin JM; Fournier A; Alexandre JM; Lombaert M; Ronco G; Bezoc JF; Desmet ; Quichaud J
J Urol Nephrol (Paris); 1976 Sep; 82(9):792-8. PubMed ID: 994296
[No Abstract] [Full Text] [Related]
19. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects.
Krouf D; Bouchenak M; Mohammedi B; Cherrad A; Belleville JL; Prost JL
Med Sci Monit; 2003 Aug; 9(8):PI109-15. PubMed ID: 12942043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
